BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 11031966)

  • 1. [Paraneoplastic retinal degeneration, cancer-associated retinopathy].
    Kuriyama M; Fujii A; Yoneda M
    Ryoikibetsu Shokogun Shirizu; 2000; (29 Pt 4):347-50. PubMed ID: 11031966
    [No Abstract]   [Full Text] [Related]  

  • 2. [Paraneoplastic retinopathy and anti-recoverin antibodies].
    Bataller L; Graus F; Dalmau J
    Neurologia; 2002 Mar; 17(3):156. PubMed ID: 11927105
    [No Abstract]   [Full Text] [Related]  

  • 3. [Paraneoplastic retinopathy in 2 patients with breast carcinoma].
    Huober J; Holz FG; Schmid H; Nölle B; Bellmann C; Krastel H; Wallwiener D; Bastert G
    Zentralbl Gynakol; 1997; 119(6):278-81. PubMed ID: 9312964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Carcinoma-associated retinopathy].
    Ohguro H; Maruyama I
    Ryoikibetsu Shokogun Shirizu; 2000; (31):73-6. PubMed ID: 11269192
    [No Abstract]   [Full Text] [Related]  

  • 5. Role of anti-recoverin autoantibodies in cancer-associated retinopathy.
    Adamus G; Guy J; Schmied JL; Arendt A; Hargrave PA
    Invest Ophthalmol Vis Sci; 1993 Aug; 34(9):2626-33. PubMed ID: 7688357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recoverin and Hsc 70 are found as autoantigens in patients with cancer-associated retinopathy.
    Ohguro H; Ogawa K; Nakagawa T
    Invest Ophthalmol Vis Sci; 1999 Jan; 40(1):82-9. PubMed ID: 9888430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Carcinoma-associated retinopathy: a review with clinical examples].
    Sobottka B; Schlote T; Besch D; Djelebova T; Wilhelm H; Zrenner E
    Klin Monbl Augenheilkd; 2000 Jan; 216(1):17-24. PubMed ID: 10702938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recoverin: a potent uveitogen for the induction of photoreceptor degeneration in Lewis rats.
    Adamus G; Ortega H; Witkowska D; Polans A
    Exp Eye Res; 1994 Oct; 59(4):447-55. PubMed ID: 7859820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low titre autoantibodies against recoverin in sera of patients with small cell lung cancer but without a loss of vision.
    Bazhin AV; Shifrina ON; Savchenko MS; Tikhomirova NK; Goncharskaia MA; Gorbunova VA; Senin II; Chuchalin AG; Philippov PP
    Lung Cancer; 2001 Oct; 34(1):99-104. PubMed ID: 11557119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recoverin as a paraneoplastic antigen in lung cancer: the occurrence of anti-recoverin autoantibodies in sera and recoverin in tumors.
    Bazhin AV; Savchenko MS; Shifrina ON; Demoura SA; Chikina SY; Jaques G; Kogan EA; Chuchalin AG; Philippov PP
    Lung Cancer; 2004 May; 44(2):193-8. PubMed ID: 15084384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer-associated retinopathy induced by both anti-recoverin and anti-hsc70 antibodies in vivo.
    Ohguro H; Ogawa K; Maeda T; Maeda A; Maruyama I
    Invest Ophthalmol Vis Sci; 1999 Dec; 40(13):3160-7. PubMed ID: 10586938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant expression of photoreceptor-specific calcium-binding protein (recoverin) in cancer cell lines.
    Maeda A; Ohguro H; Maeda T; Wada I; Sato N; Kuroki Y; Nakagawa T
    Cancer Res; 2000 Apr; 60(7):1914-20. PubMed ID: 10766180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Paraneoplastic neurologic syndrome--neoplasms and neuroimmune system].
    Inuzuka T; Tanaka K
    Nihon Naika Gakkai Zasshi; 1998 Jun; 87(6):1138-43. PubMed ID: 9702029
    [No Abstract]   [Full Text] [Related]  

  • 14. Fluorescein angiographic findings in a case of cancer-associated retinopathy.
    Masaoka N; Emoto Y; Sasaoka A; Fukushima A; Ueno H; Ohguro H
    Retina; 1999; 19(5):462-4. PubMed ID: 10546949
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical and immunologic aspects of cancer-associated retinopathy.
    Ohguro H; Yokoi Y; Ohguro I; Mamiya K; Ishikawa F; Yamazaki H; Metoki T; Takano Y; Ito T; Nakazawa M
    Am J Ophthalmol; 2004 Jun; 137(6):1117-9. PubMed ID: 15183799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cancer-associated retinopathy antigen is a recoverin-like protein.
    Thirkill CE; Tait RC; Tyler NK; Roth AM; Keltner JL
    Invest Ophthalmol Vis Sci; 1992 Sep; 33(10):2768-72. PubMed ID: 1388144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antirecoverin autoantibodies in the patient with non-small cell lung cancer but without cancer-associated retinopathy.
    Savchenko MS; Bazhin AV; Shifrina ON; Demoura SA; Kogan EA; Chuchalin AG; Philippov PP
    Lung Cancer; 2003 Sep; 41(3):363-7. PubMed ID: 12928127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer-associated retinopathy syndrome: a case of small cell lung cancer expressing recoverin immunoreactivity.
    Matsubara S; Yamaji Y; Fujita T; Kanayama T; Yamadori I; Sato M; Fujita J; Shiotani T; Takahara J
    Lung Cancer; 1996 Jun; 14(2-3):265-71. PubMed ID: 8794409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human melanoma-associated retinopathy (MAR) antibodies alter the retinal ON-response of the monkey ERG in vivo.
    Lei B; Bush RA; Milam AH; Sieving PA
    Invest Ophthalmol Vis Sci; 2000 Jan; 41(1):262-6. PubMed ID: 10634629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retinal dysfunction in cancer-associated retinopathy is improved by Ca(2+) antagonist administration and dark adaptation.
    Ohguro H; Ogawa K; Maeda T; Maruyama I; Maeda A; Takano Y; Nakazawa M
    Invest Ophthalmol Vis Sci; 2001 Oct; 42(11):2589-95. PubMed ID: 11581204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.